Jim Simons
CLBT icon

Jim Simons’s Cellebrite CLBT Stock Holding History

Jim Simons’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4M Buy
2,860,639
+365,700
+15% +$5.51M 0.06% 396
2025
Q4 		$45M Sell
2,494,939
-407,166
-14% -$7.31M 0.07% 320
2025
Q3 		$53.8M Buy
2,902,105
+215,766
+8% +$3.39M 0.07% 329
2025
Q2 		$43M Buy
2,686,339
+76,000
+3% +$1.35M 0.06% 395
2025
Q1 		$50.7M Buy
2,610,339
+979,900
+60% +$20.6M 0.08% 316
2024
Q4 		$35.9M Buy
1,630,439
+115,939
+8% +$2.23M 0.05% 433
2024
Q3 		$25.5M Buy
1,514,500
+330,800
+28% +$4.91M 0.04% 558
2024
Q2 		$14.1M Buy
1,183,700
+214,600
+22% +$2.4M 0.02% 750
2024
Q1 		$10.7M Sell
969,100
-82,056
-8% -$838K 0.02% 954
2023
Q4 		$9.1M Buy
1,051,156
+727,756
+225% +$5.66M 0.01% 995
2023
Q3 		$2.47M Buy
323,400
+126,100
+64% +$946K ﹤0.01% 1732
2023
Q2 		$1.42M Buy
197,300
+120,700
+158% +$704K ﹤0.01% 2221
2023
Q1 		$466K Buy
76,600
+63,300
+476% +$343K ﹤0.01% 2920
2022
Q4 		$58K Buy
+13,300
New +$59.4K ﹤0.01% 3769

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Jim Simons's CLBT Position: Q1 2026 in Review

Jim Simons increased its Cellebrite (CLBT) stake by 15% in Q1 2026, buying an estimated $5.51M and bringing the position to 2,860,639 shares worth $39.4M. The position accounts for 0.06% of the portfolio, ranked #396.

Jim Simons first reported a position in CLBT in Q4 2022 and has held it in 14 quarters since. The position peaked at $53.8M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Jim Simons held 2,860,639 shares of Cellebrite worth $39.4M as of Q1 2026.
  • Jim Simons bought 365,700 Cellebrite shares in Q1 2026, an estimated $5.51M.
  • Cellebrite made up 0.06% of Jim Simons's portfolio in Q1 2026, its #396 holding.
  • Jim Simons first reported a position in Cellebrite in Q4 2022 and has held it in 14 quarters since.
  • Jim Simons's Cellebrite position peaked at $53.8M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.